Skip to content

Clinical trials

Tuberous Sclerosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberous Sclerosis Country / region: United States Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20052
20072
20082
20093
20103
20111
20122
20134
20143
20152
20165
20174
20184
20191
20203
20214
20227
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Recruiting7
Active, not recruiting6
Terminated5
Enrolling by invitation2
Withdrawn2
Available1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital Medical Center, Cincinnati7
Jazz Pharmaceuticals5
National Heart, Lung, and Blood Institute (NHLBI)5
University of California, Los Angeles5
Longboard Pharmaceuticals3
Marinus Pharmaceuticals3
Novartis Pharmaceuticals3
Boston Children's Hospital2
Dana-Farber Cancer Institute2
NYU Langone Health2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberous Sclerosis62
Epilepsy14
Seizures11
Lymphangioleiomyomatosis10
Epilepsies, Myoclonic7
Lennox Gastaut Syndrome7
Autistic Disorder6
Hereditary Sensory and Autonomic Neuropathies4
Angelman Syndrome3
Angiofibroma3

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.